Sign in to view content

RGX-314 for Neovascular AMD: Ongoing Phase I/IIa Results for Cohorts 1-5

Arshad M. Khanani, MD, MA, FASRS

Video
Published 2020

Related

Intraoperative Use of Microscope-Integrated OCT for Subretinal Gene Therapy
Ninel Z. Gregori, MD
Annual Meeting Talks
2018
Effect of Adjuvant Topical Dorzolamide-Timolol Versus Placebo in Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial
Jason Hsu, MD
On Demand Cases, Courses, and Papers
2020
Preliminary Results from a First-in-human Phase I/II Gene Therapy Study (FOCUS) of Subretinally Delivered GT005, an Investigational AAV2 Vector, in Patients with Geographic Atrophy Secondary to Age-related Macular Degeneration
Jared S. Nielsen, MD, MBA
Updates from the Field
2022

Category: AMD-Neovascular

See more